Skip to main content
The Capital View · TAM_CV_09

The Capital Brief

What the Current Deal Structure Is Not Pricing

In a hurry? Read the executive summary.

TAM-CV.09 · The Capital View · The Approximate Mind

The investment thesis for AI-disrupted service rollups in fragmented industries is structurally sound. The demographic tailwinds are real and durable. The supply gaps are not cyclical. The orchestration layer creates genuine value. The dual-asset exit math is compelling. The firms building toward this thesis are not wrong about the opportunity.

They are mispricing a risk that is not operational, not regulatory in the conventional sense, and not technological. It sits outside the standard risk register, which is why most current deal structures do not model it. It compounds with the same asymmetry as the data advantage the thesis depends on. And it becomes acute within a typical hold period.

The risk is this: the capital structure that organizes the AI transition in fragmented service industries creates a visible and growing gap between who benefits from the transition and who waits for it. When that gap becomes politically legible, it becomes a target. The window between deployment and legibility is the hold period. The firms that understand this are building differently than the firms that do not.

This brief names the unmodeled risk, identifies where it is most acute, and makes the case that building for the full demand curve is not a concession to social pressure. It is risk-adjusted return modeling that most current deal teams are not doing.

The Unmodeled Risk
#

Private equity in healthcare services is already under political and regulatory pressure that was not anticipated in the deal structures of five years ago. The veterinary rollup story is the clearest data point: aggressive consolidation, rapid price increases, documented quality concerns, congressional attention, state-level regulatory proposals, and exit multiples that are beginning to reflect the political risk that was not priced at entry. The elder care story is three to five years behind the veterinary story. The behavioral health story is two to three years behind elder care. The childcare story has not yet begun.

The pattern in each case is the same. Consolidation produces efficiency gains and price increases. The efficiency gains are real. The price increases are also real, and they fall hardest on the populations with the least purchasing power and the least ability to absorb them or substitute away. The political response follows from the visibility of who bears the cost. In industries that touch vulnerable populations at moments of high emotional salience, the political response is faster and sharper than in industries that do not.

The industries where the AI rollup thesis is most compelling are the industries where the political exposure is highest.

This is not a coincidence. The same features that make an industry attractive for the thesis, fragmented supply, structural demand excess, vulnerable populations, coordination overhead that people feel acutely, are the features that make it politically exposed when the consolidation becomes visible. The thesis and the risk are the same phenomenon viewed from different angles.

The firms that price this correctly are building for a specific outcome: the orchestration layer reaches far enough down the income distribution that the political constituency for dismantling it is smaller than the political constituency that benefits from it. This is not philanthropy. It is the calculus of operating in industries where regulatory risk is a function of who the product excludes.

The Data Asset Problem
#

The thesis depends on accumulated outcome data being a compounding asset. More deployment, better data, stronger proof of care quality, higher premium from payers and families choosing between providers. The early mover builds a moat that late entrants cannot close by deploying the same platform, because the platform is available but the data is not.

This is correct within the bounds of the current market structure. Those bounds are narrower than most deal models assume.

If the platform standardizes care delivery across all users, the outcomes it produces converge across the rollup and the independent agencies using the same orchestration layer. The data that was a differentiator becomes a baseline. The moat was lead time, and lead time depreciates. Whether it depreciates within the hold period is the bet most deal structures are making without naming it as a bet.

The data asset has a second problem that is less often modeled. Outcome data accumulated from a narrow deployment, serving primarily the private-pay tier in well-resourced markets, is less valuable at exit than outcome data accumulated from broad deployment across the income distribution. The acquirers who will pay technology multiples for the platform are acquirers who want to deploy it at scale, into payer relationships, into government contracts, into health system partnerships. Those acquirers need proof of performance across populations, not proof of performance for one population. The narrow dataset is worth less to them than the broad one, and the difference in valuation is larger than most deal models reflect.

The firm that deploys into the Medicaid population alongside the private-pay population is building a more valuable data asset. The firm that serves only private pay is building a more marketable story with a shorter shelf life.

The half-life of the narrow dataset is a function of how quickly the market converges and how quickly sophisticated acquirers learn to ask the question. Both are accelerating.

The Agent-to-Agent Audit
#

The agent-to-agent scenario described in the first essay of this arc is not speculative. Personal AI agents that can query service providers, compare outcomes data, evaluate pricing, and route to the best match are in early deployment now and will be standard within the hold period of deals being structured today.

When the consumer’s agent can see your margin, the margin has to be justified by genuine value creation. Not by friction. Not by the information asymmetry that made the original business possible. By actual coordination value, outcome improvement, and horizontal integration that no agent can replicate by querying individual providers.

The agent-to-agent transition is an audit of every basis point of rent extraction in the current pricing structure. The toll booth that survives the audit is the toll booth attached to genuine value. The toll booth that does not survive is the toll booth that was operating on information asymmetry, and information asymmetry is exactly what AI agents are designed to dissolve.

This audit arrives within the hold period. The firms that have built genuine value into the orchestration layer are positioned well for it. The firms that have built margin into the friction of a fragmented market are not, and they will discover this at the moment of maximum inconvenience, which is during a sale process.

The preparation for the agent-to-agent audit is not a technology decision. It is a business model decision: what is the margin attached to, and can it survive transparency?

The Blue Mug Argument
#

Every industry where the enclosure of coordination is underway has a version of the blue mug: the specific, irreducible thing that the orchestration layer exists to protect and that the metrics cannot capture. In elder care it is the knowledge accumulated through eight months of Tuesdays in a specific room with a specific person. In behavioral health it is what the therapist knows about this patient that the intake form does not ask. In childcare it is how this child comes out of nap time. In home services it is the contractor who knows the floor runs slightly uphill toward the east wall.

These are not edge cases. They are the core of what each service provides when it is working. The orchestration layer exists to handle everything around them so that the human in the room can attend to them fully. This is the value proposition, stated honestly.

The firms that build the infrastructure with this understanding, that orient the optimization toward protecting the irreducible thing rather than replacing it, produce better outcomes, retain better staff, generate better data, and accumulate better political standing than the firms that optimize the metrics and lose the thread of what the metrics are measuring.

This is not a values argument. It is a performance argument. The infrastructure that forgets what it is for gets competed away by the infrastructure that remembers.

The operationalization of this argument is specific: what is the blue mug in the industry you are entering, how do you know whether your orchestration layer is protecting it or eliminating it, and what is the measurement cadence that would tell you which is happening before the exit process reveals it.

Most current deal structures do not ask this question. The firms that start asking it now are the ones that will be able to answer it when the question is asked of them, by acquirers, by regulators, and by the political constituencies that are paying attention to whether the transition is working for the people inside it.

The Addressable Market
#

The fragmented service industries where the four conditions hold simultaneously, structural demand excess, fragmented supply, labor as primary cost driver, high coordination overhead borne by an invisible party, represent a combined addressable market that current deal sizing consistently underestimates because it models the private-pay tier and treats the rest as future optionality.

It is not future optionality. It is the market.

In elder care alone, the population that needs coordinated aging-at-home services and cannot currently access or afford them exceeds twenty million Americans. The behavioral health coordination gap is comparable in scale. The childcare coordination gap is larger. The legal services gap for individuals and small businesses has never been adequately measured because the people who need the service have no way to signal demand in a market they cannot enter.

The total addressable market for well-designed AI coordination across these industries, priced to reach the full demand curve rather than only the private-pay segment, is the largest services market that private capital has not yet sized correctly. The firms that recognize this and build for it will not be sacrificing return for impact. They will be entering a market that their competitors are not competing in yet, with the data advantages that accrue to early deployment at scale, and with the political durability that comes from building something a broad constituency depends on rather than something a narrow constituency can afford.

The window for building at this scale with these advantages is the current investment cycle.

The firms that understand what they are building, in every room and at every tier, are the firms that will be able to hold it.

The case made here assumes that capital owns the coordination infrastructure. That assumption is being contested. If AI can perform the coordination function that justified the management layer, the management layer is removable, and the question of who captures the savings when it is removed is not settled by the technology. It is settled by the ownership structure. The essays that follow this one examine what happens when that contest becomes visible: the management strip as PE’s next value creation play (TAM-CV.10), the competition to own the coordination platform itself (TAM-CV.11), and the cooperative alternative that capital’s instruments cannot measure and capital’s structure cannot reach (TAM-CV.12).

This is the ninth essay in The Capital View, a twelve-essay arc examining the AI transition from the position of capital. It is written in a different register from the eight essays that precede it: for the practitioner audience, in the language of deal structure and risk modeling rather than philosophical reflection. The arguments it makes in this register are developed more fully, with their human weight intact, in the preceding essays. TAM-CV.01 through TAM-CV.06 examine the thesis through specific people in specific rooms. TAM-CV.07 names the general pattern. TAM-CV.08 traces the asymmetric deployment and its feedback into AI development. This essay makes the case that the asymmetry is not just an equity concern but a structural risk that current deal models are not pricing. The three essays that follow (TAM-CV.10 through TAM-CV.12) extend the arc to engage the structural insight from the Coordination cluster (TAM-RIM.6), examining what happens when the coordination function the original arc assumed capital would own becomes contestable. Practitioners who want the underlying argument in full should read the arc from the beginning. The blue mug is in TAM-CV.05.

References
#

Private Equity Risk Modeling and Healthcare

Appelbaum, Eileen, and Rosemary Batt. Private Equity at Work: When Wall Street Manages Main Street. Russell Sage Foundation, 2014.

Scheffler, Richard M., et al. “Monetizing Medicine: Private Equity and Competition in Physician Practice Markets.” Health Affairs, vol. 42, no. 6, 2023, pp. 765-774.

Singh, Yashaswini, et al. “Association of Private Equity Acquisition of Physician Practices with Changes in Health Care Spending and Utilization.” JAMA Health Forum, vol. 3, no. 9, 2022.

Platform Economics, Moats, and Valuation

Evans, David S., and Richard Schmalensee. Matchmakers: The New Economics of Multisided Platforms. Harvard Business Review Press, 2016.

Mauboussin, Michael J. More Than You Know: Finding Financial Wisdom in Unconventional Places. Columbia University Press, 2006.

Parker, Geoffrey G., et al. Platform Revolution: How Networked Markets Are Transforming the Economy and How to Make Them Work for You. W. W. Norton, 2016.

The Agent Economy and Market Transparency

Brynjolfsson, Erik, et al. “Artificial Intelligence and the Modern Productivity Paradox.” The Economics of Artificial Intelligence: An Agenda, edited by Ajay Agrawal et al., University of Chicago Press, 2019, pp. 23-57.

Varian, Hal R. “Artificial Intelligence, Economics, and Industrial Organization.” The Economics of Artificial Intelligence: An Agenda, edited by Ajay Agrawal et al., University of Chicago Press, 2019, pp. 399-419.

Regulatory Risk and Political Economy

Philippon, Thomas. The Great Reversal: How America Gave Up on Free Markets. Harvard University Press, 2019.

Wu, Tim. The Curse of Bigness: Antitrust in the New Gilded Age. Columbia Global Reports, 2018.

Addressable Market and Demand Suppression

Paraprofessional Healthcare Institute. Caring for the Future: The Power and Potential of America’s Direct Care Workforce. PHI, 2021.

Reinhard, Susan C., et al. Valuing the Invaluable: 2023 Update. AARP Public Policy Institute, 2023.

Sen, Amartya. Development as Freedom. Knopf, 1999.

How this essay connects to others across The Approximate Mind.

The Interrogator describes the job that doesn't exist — the epistemological architect who questions what the optimizer is missing; The Capital Brief is the document that job would produce: the risk analysis that current deal structures are not doing, addressed to the people making the decisions.
The Moneyrelated
The Money makes the fiscal case for the floor; The Capital Brief makes the risk case to capital for building toward the full demand curve — both documents are addressed to different audiences about the same structural gap, and both argue that the gap is not only a moral problem but an arithmetic one.
The Two Civilizations are a political choice; The Capital Brief argues they are also a risk-adjusted return question — the firms building toward the full demand curve are building toward the civilization that holds, and the capital brief is the investment case for making that choice before the window closes.
Private Equity Risk Modeling and Healthcare
  1. Appelbaum, Eileen, and Rosemary Batt. Private Equity at Work: When Wall Street Manages Main Street. Russell Sage Foundation, 2014.
  2. Scheffler, Richard M., et al. “Monetizing Medicine: Private Equity and Competition in Physician Practice Markets.” Health Affairs, vol. 42, no. 6, 2023, pp. 765-774.
  3. Singh, Yashaswini, et al. “Association of Private Equity Acquisition of Physician Practices with Changes in Health Care Spending and Utilization.” JAMA Health Forum, vol. 3, no. 9, 2022.
Platform Economics, Moats, and Valuation
  1. Evans, David S., and Richard Schmalensee. Matchmakers: The New Economics of Multisided Platforms. Harvard Business Review Press, 2016.
  2. Mauboussin, Michael J. More Than You Know: Finding Financial Wisdom in Unconventional Places. Columbia University Press, 2006.
  3. Parker, Geoffrey G., et al. Platform Revolution: How Networked Markets Are Transforming the Economy and How to Make Them Work for You. W. W. Norton, 2016.
The Agent Economy and Market Transparency
  1. Brynjolfsson, Erik, et al. “Artificial Intelligence and the Modern Productivity Paradox.” The Economics of Artificial Intelligence: An Agenda, edited by Ajay Agrawal et al., University of Chicago Press, 2019, pp. 23-57.
  2. Varian, Hal R. “Artificial Intelligence, Economics, and Industrial Organization.” The Economics of Artificial Intelligence: An Agenda, edited by Ajay Agrawal et al., University of Chicago Press, 2019, pp. 399-419.
Regulatory Risk and Political Economy
  1. Philippon, Thomas. The Great Reversal: How America Gave Up on Free Markets. Harvard University Press, 2019.
  2. Wu, Tim. The Curse of Bigness: Antitrust in the New Gilded Age. Columbia Global Reports, 2018.
Addressable Market and Demand Suppression
  1. Paraprofessional Healthcare Institute. Caring for the Future: The Power and Potential of America’s Direct Care Workforce. PHI, 2021.
  2. Reinhard, Susan C., et al. Valuing the Invaluable: 2023 Update. AARP Public Policy Institute, 2023.
  3. Sen, Amartya. Development as Freedom. Knopf, 1999.